Assuntos
Colo do Útero , Gravidez Heterotópica , Feminino , Humanos , Gravidez , Colo do Útero/diagnóstico por imagem , Colo do Útero/patologia , Gravidez Ectópica/diagnóstico por imagem , Gravidez Heterotópica/diagnóstico por imagem , Gravidez Heterotópica/diagnóstico , Gravidez Heterotópica/cirurgia , Ultrassonografia Pré-NatalAssuntos
Complicações na Gravidez/terapia , Doença de von Willebrand Tipo 2/terapia , Adulto , Criança , Feminino , Seguimentos , Testes Hematológicos , Humanos , Gravidez , Complicações na Gravidez/sangue , Complicações na Gravidez/diagnóstico , Doença de von Willebrand Tipo 2/sangue , Doença de von Willebrand Tipo 2/diagnósticoAssuntos
Falso Aneurisma/patologia , Cesárea/efeitos adversos , Imageamento Tridimensional , Tomografia Computadorizada por Raios X , Ultrassonografia Doppler em Cores , Embolização da Artéria Uterina/métodos , Artéria Uterina/patologia , Adulto , Feminino , Humanos , Gravidez , Resultado do TratamentoRESUMO
The term chorioamnionitis is used to describe an intrauterine status of infection/inflammation of either mixed fetal-maternal (choriodecidual space) or fetal origin (chorioamniotic membranes, amniotic fluid, umbilical cord). Histological, microbiological, biochemical and clinical criteria are used to define chorioamnionitis. Histopathological examination of the placenta is the gold standard for evaluating antenatal inflammatory processes that might influence fetal development. Chorioamnionitis is the leading cause of very preterm delivery and its incidence increases with decreasing gestational age. Therefore, it contributes to the high morbidity and mortality of infants born prematurely. In the last decades, several studies have been performed to assess a gestation-independent effect of chorioamnionitis on neonatal and long-term outcome with variable results. The discrepancy observed across studies may be attributable to differences in inclusion and exclusion criteria, disease definitions, methods, and whether potential confounding factors such as gestational age were considered. As underlined by several Authors, the increasingly widespread use of antenatal steroids may have contributed to improve neonatal outcome and can therefore partially explain the different results between studies. In the current review we aim to give an overview and synthesis of a vast amount of existing literature on the association between antenatal infection/inflammation and neonatal and long-term outcome.
Assuntos
Corioamnionite , Doenças do Prematuro/etiologia , Corioamnionite/imunologia , Feminino , Humanos , Recém-Nascido , Recém-Nascido Prematuro , GravidezRESUMO
The number of women with congenital heart disease reaching childbearing age is constantly increasing due to the advances achieved in cardiac surgery during the past decades. The significant physiological haemodynamic changes and adaptations of the cardiovascular system associated with pregnancy, birth and puerperium increases the cardiovascular risk to pregnant women with congenital heart disease. It is therefore necessary not only the awareness of these haemodynamic changes and risks, but also a multidisciplinary approach that involves preconception counseling, choosing the best contraceptive method, close surveillance during pregnancy, delivery and puerperium. The purpose of this article is to review the major risks associated with pregnancy in women with CHD and to provide an indication on the best contraceptive method and cares during pregnancy in these patients.
Assuntos
Cardiopatias Congênitas/terapia , Cardiopatias/congênito , Cardiopatias/terapia , Complicações Cardiovasculares na Gravidez/terapia , Feminino , Cardiopatias Congênitas/tratamento farmacológico , Cardiopatias/tratamento farmacológico , Humanos , Gravidez , Complicações Cardiovasculares na Gravidez/tratamento farmacológicoRESUMO
Nineteen pregnant women with uncomplicated pregnancies were studied during the first, second, and third trimesters. We measured the following hemostatic parameters: prothrombin time, activated partial thromboplastin time, fibrinogen, antithrombin III, protein C, protein S, platelet number and volume. Platelet function was examined by a cytofluorimetric method, using an anti-GPM-140 antibody which is directed against a platelet alpha granule membrane protein. Activated platelets were expressed as a percentage of the GMP-140-positive platelets over total platelets. Fibrinogen levels showed a steady increase during pregnancy; conversely prothrombin time, activated partial thromboplastin time, protein C, and antithrombin III showed no significant modifications and remained within the reference range. There was a decrease of protein S activity throughout pregnancy, although protein S antigen did not follow this trend. The decrease occurred early in pregnancy and persisted during the second and third trimesters, reaching a stable plateau. We observed no platelet volume change or activation: the percentage of activated platelets was within the normal reference range, even in late pregnancy.